yfimuna.wordpress.com
The Miami-based biotechnology developmentcompany (AMEX: OPK) is looking for monety to support clinical trials in the ophthalmologuy field. “We are pleased to receive theses funds and appreciate the confidence of the investorzsin Opko’s future success,” Opko Chairmanb and CEO Dr. Phillip Frosy said in a news release. Three entitied controlled by Taiwan-based Ruentex Groupl – Chung Chia Co. Ltd., Grandtime Associateas Ltd. and Gold Sino Assets Ltd. – investeds a combined $20 million in Opko. Ruentex’s operations include constructionand development, finance, medical services, retail and Miami-based tobacco company (NYSE: VGR) investedf $5 million in Opko.
Frost beneficially owns 11.5 perceng of Vector Group, Opko stated in a filingb on Monday. Two groups controlled by Greenwich, Conn.-baserd Oracle Partners, one of the world’ds biggest health care focused hedge invested acombined $5 million in The remaining $1 million came from Nora Real which is controlled by formedr director Carlo Salvi. Frost got a spot on Teva’s board after the Israeli company acquiredhis Miami-base Opko shares were up 7 cents to $1.27 in morningg trading.
No high/low information was
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment